Summary

The global Venous Interventional Devices market is projected to grow from US$ 2260 million in 2025 to US$ 4160 million by 2032, at a CAGR of 9.2% (2026-2032), driven by critical product segments and diverse end‑use applications.

Venous Interventional Devices are minimally invasive medical devices used through percutaneous vascular access or endovenous approaches to treat venous thrombosis, venous outflow obstruction, venous thromboembolic risk, and superficial venous reflux. Major product forms include mechanical and aspiration thrombectomy devices, catheter-directed thrombolysis devices, dedicated deep venous stents, vena cava filters and retrieval devices, and endovenous ablation or closure systems based on radiofrequency, laser, mechanochemical, cyanoacrylate, microwave, and related technologies. Key performance attributes vary by modality and include catheter deliverability, thrombus-removal efficiency, blood-loss management, radial strength and flexibility of venous stents, filter capture and retrievability, and energy delivery, temperature control, and target-vein closure performance. Venous Interventional Devices are primarily used in deep vein thrombosis, chronic venous outflow obstruction, venous thromboembolism protection, and superficial venous insufficiency, with major clinical users including vascular surgery, interventional radiology, cardiovascular intervention, and dedicated vein-care practices.

Key Findings
Endovenous ablation and closure represents the largest product segment, accounting for approximately 40% of the global market
Venous thrombectomy and catheter-directed thrombolysis account for nearly 30% and remain among the most active areas of technology development
North America remains the leading region for high-value venous thrombectomy and dedicated venous intervention innovation
Chinese manufacturers are expanding from filters and superficial venous therapy into venous stents and mechanical thrombectomy

Market Trends
Venous Interventional Devices are evolving from relatively mature vena cava filtration and superficial venous ablation toward higher-value deep venous thrombectomy and venous outflow reconstruction. Technology development in deep vein thrombosis is moving beyond basic clot removal toward more complete thrombus clearance, lower thrombolytic exposure, reduced procedural blood loss, shorter treatment times, and improved treatment of subacute, organized, chronic, and in-stent thrombotic material. Dedicated venous stents are increasingly differentiated by radial strength, compression resistance, flexibility, and long-term patency. Superficial venous therapy remains anchored by established radiofrequency and laser technologies, while mechanochemical ablation, cyanoacrylate closure, and microwave-based approaches broaden treatment choice. New peripheral venous mechanical thrombectomy systems continued to receive FDA clearance in 2026, indicating that product innovation and new market entry remain active.

Market Dynamics
Drivers
Market development is supported by population aging, obesity, sedentary lifestyles, and greater clinical recognition of the long-term consequences of deep vein thrombosis, post-thrombotic syndrome, chronic venous obstruction, and symptomatic venous reflux. Mechanical thrombectomy can reduce reliance on prolonged catheter-directed thrombolysis in selected patients, dedicated venous stents improve device suitability for deep venous reconstruction, and endovenous ablation and closure shorten treatment and recovery for superficial venous disease. At the product level, major medical device companies are expanding integrated venous portfolios. BD, for example, currently offers radiofrequency ablation, dedicated venous stenting, mechanical aspiration thrombectomy, and vena cava filtration technologies, illustrating the shift from isolated products toward broader venous-care platforms.

Restraints
Key restraints include procedure cost, differences in clinical evidence, reimbursement variability, and physician practice patterns across regions. High-value mechanical thrombectomy systems and dedicated venous stents often require substantial disposable-device expenditure as well as access to advanced imaging, catheterization laboratories, and experienced interventional teams, which can limit adoption in resource-constrained markets. Long-term evaluation standards also vary across treatment modalities, while anticoagulation, compression therapy, and conventional surgery remain appropriate for selected patients. In superficial venous treatment, technology maturity is increasing price competition and making product differentiation more difficult, placing pressure on margins for manufacturers with limited technological or channel advantages.

Opportunities
The strongest opportunities are concentrated in mechanical thrombectomy for deep vein thrombosis, chronic venous obstruction, in-stent restenosis or thrombosis, and more complex venous reconstruction. Compared with mature vena cava filtration and superficial thermal ablation, these areas still offer greater room for penetration and depend more heavily on dedicated device design. Product development is increasingly focused on lowering blood loss, improving thrombus-removal efficiency, reducing thrombolytic use, and treating more complex clot morphology. Local manufacturers in markets such as China are also moving from radiofrequency ablation and vena cava filters into venous stents and mechanical thrombectomy. Endovastec's Fishhawk mechanical thrombectomy device received NMPA approval in 2026 for percutaneous removal of acute iliac and femoral deep venous thrombus, illustrating the expansion of domestic manufacturers into higher-value venous thrombectomy.

Challenges
Long-term success in Venous Interventional Devices requires clinical evidence, physician training, and commercialization capabilities to develop in parallel. Deep venous anatomy is complex, and lesion length, thrombus age, flow conditions, and prior interventions can materially affect procedural outcomes. New entrants that obtain regulatory clearance must still establish evidence on patency, recurrence, complications, and reintervention while building hospital access and specialist physician education. Competitive dynamics also differ significantly across thrombectomy, venous stents, filters, and superficial venous closure. Mature categories face greater pricing pressure, whereas innovative platforms must absorb higher research, clinical, regulatory, and market-development costs, increasing the likelihood of further industry segmentation.

Industry Chain Analysis
The upstream supply chain for Venous Interventional Devices includes nitinol, stainless steel, medical polymers, catheter tubing, radiopaque materials, radiofrequency and laser components, precision drive mechanisms, and aspiration-control components. Cost structures vary significantly by product. Venous stents and vena cava filters rely heavily on nitinol processing, heat treatment, braiding, or laser cutting; mechanical thrombectomy systems depend more on catheter architecture, drive mechanisms, aspiration control, and blood-management design; and radiofrequency, laser, and microwave products combine capital equipment with disposable treatment catheters or fibers. Raw material cost alone does not determine product value, as device engineering, clinical validation, regulatory approval, and precision manufacturing contribute materially to the final value proposition.

The midstream consists of developers and manufacturers of dedicated venous intervention devices, where value creation is concentrated in device design, indication expansion, clinical evidence, physician education, and commercial access. Downstream users include hospital vascular surgery departments, interventional radiology units, cardiovascular intervention centers, ambulatory surgery centers, and dedicated vein-care practices. High-value deep venous procedures generally depend more heavily on tertiary hospitals, advanced imaging, and specialized interventional teams, while superficial venous ablation and closure can extend into ambulatory and office-based settings in more developed markets. Disposable products are driven primarily by procedure volume, whereas radiofrequency, laser, and microwave systems combine installed equipment with recurring disposable sales.

Segment Insights
By product structure, endovenous ablation and closure accounts for approximately 40% of the current market and remains the largest segment, supported by a large patient population with superficial venous insufficiency, mature clinical adoption of radiofrequency and laser treatment, and broad treatment settings. Venous thrombectomy and catheter-directed thrombolysis represent close to 30% of the market. Although smaller than superficial venous treatment, this segment is experiencing more active innovation and clinical penetration, particularly in mechanical thrombectomy. Dedicated deep venous stents account for slightly less than one-fifth of the market and primarily address iliofemoral and other deep venous outflow obstruction, while vena cava filters and retrieval devices represent a little over one-tenth and are comparatively mature.

From a technology perspective, market value is progressively shifting toward more complex deep venous intervention. Thermal ablation has an established role in superficial venous disease, while non-thermal closure technologies continue to expand in selected patient groups. Mechanical thrombectomy is differentiated by the potential to reduce thrombolytic exposure and provide immediate clot removal, while dedicated venous stents have evolved from general peripheral stents toward designs optimized for venous anatomy and compressive environments. Competitive parameters increasingly include patency, compression resistance, flexibility, deployment accuracy, and procedural efficiency rather than simple product availability.

Downstream Market Opportunities
Downstream opportunities are concentrated in deep vein thrombosis, chronic venous outflow obstruction, and superficial venous insufficiency. Patients with high thrombus burden, iliofemoral disease, or elevated risk of post-thrombotic syndrome represent particularly valuable use cases for mechanical thrombectomy and venous reconstruction. Chronic venous obstruction and non-thrombotic iliac venous lesions support further penetration of dedicated venous stents. In superficial venous disease, future expansion is more closely linked to broader treatment access, ambulatory procedures, and patient preference for shorter recovery and lower procedural trauma. As clinical pathways and physician training become more standardized, Venous Interventional Devices can address a larger proportion of patients who have historically received conservative therapy or conventional surgery.

Regional Insights
North America is a major market for Venous Interventional Devices and has the highest concentration of innovation in high-value mechanical thrombectomy and deep venous intervention. The region benefits from mature interventional infrastructure, strong physician adoption of new thrombectomy and venous stenting technologies, and continued regulatory entry of new devices. Europe has developed a broad group of specialized manufacturers in dedicated venous stents, vena cava filters, endovenous laser systems, and radiofrequency therapy, resulting in a more fragmented supplier structure and a stronger role for focused mid-sized companies.

China is undergoing a rapid upgrade in product mix. Domestic suppliers are expanding from relatively mature vena cava filters and superficial venous radiofrequency systems into dedicated venous stents, mechanical thrombectomy, and broader venous intervention portfolios. Endovastec's mechanical thrombectomy product entered regulatory and commercial deployment in 2026, while Acotec has established product lines in radiofrequency ablation and peripheral thrombus aspiration, demonstrating the movement of domestic supply toward higher-barrier venous intervention categories. Japan and South Korea retain selected specialist manufacturers in laser and radiofrequency technologies, whereas Southeast Asia and several other emerging markets remain more dependent on imported devices and multinational distribution channels.

Competitive Landscape Analysis
The global Venous Interventional Devices market has a layered competitive structure comprising diversified medical device groups, specialized venous intervention companies, and regional manufacturers. Medtronic and BD maintain broad product coverage across superficial venous therapy, venous stenting, and other venous technologies, while Stryker strengthened its presence in venous thromboembolism through the acquisition of Inari Medical in February 2025, highlighting the continuing integration of specialized venous technologies into larger interventional platforms. Europe includes focused manufacturers such as Optimed, Bentley, Biolitec, and LSO Medical in dedicated venous stenting and endovenous ablation, while China has developed a growing base of suppliers including Endovastec, Zylox-Tonbridge, Acotec Scientific, LifeTech Scientific, and Shanghai EndoVas Medical Technologies, alongside numerous regional manufacturers in radiofrequency ablation, vena cava filtration, and related products. Competition is gradually shifting from product registration and pricing toward clinical evidence, dedicated device performance, physician training, hospital access, and portfolio breadth. In higher-barrier segments such as mechanical thrombectomy and deep venous reconstruction, innovation capability and clinical validation remain central to long-term competitive positioning.

Report Scope
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Venous Interventional Devices market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.

Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation
By Company
Medtronic
BD
Stryker
Boston Scientific
Cook Medical
Penumbra
Merit Medical
Abbott
Argon Medical
Philips
AngioDynamics
Cordis
B. Braun
Bentley
Optimed
Biolitec
LSO Medical
F Care Systems
Balton
ALN
Acotec Scientific
Zylox-Tonbridge
Endovastec
LifeTech Scientific
APT Medical
Shanghai EndoVas Medical Technologies
Mianyang Leader Electronics
ECO Medical Technology
UNITAC
WONTECH
RF Medical

Segment by Type
Venous Thrombectomy & CDT
Deep Venous Stenting
Vena Cava Filtration & Retrieval
Endovenous Ablation & Closure
Other

Segment by Treatment Mechanism
Mechanical & Aspiration Thrombectomy
Pharmacomechanical & Infusion Therapy
Venous Stenting
Vena Cava Filtration
Thermal Ablation
Non-thermal Closure

Segment by Clinical Indication
Deep Vein Thrombosis
Chronic Venous Outflow Obstruction
VTE Risk Protection
Superficial Venous Insufficiency
Other

Segment by Application
Iliofemoral & Other Deep Veins
Inferior Vena Cava
Great & Small Saphenous Veins
Other

Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
Europe
Germany
France
U.K.
Italy
Russia
Central and South America
Brazil
Argentina
Rest of Central and South America
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa

Chapter Outline
Chapter 1: Defines the Venous Interventional Devices study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.

Why This Report
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Venous Interventional Devices: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Venous Interventional Devices Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Venous Thrombectomy & CDT
1.2.3 Deep Venous Stenting
1.2.4 Vena Cava Filtration & Retrieval
1.2.5 Endovenous Ablation & Closure
1.2.6 Other
1.3 Market Segmentation by Treatment Mechanism
1.3.1 Global Venous Interventional Devices Market Size by Treatment Mechanism, 2021 vs 2025 vs 2032
1.3.2 Mechanical & Aspiration Thrombectomy
1.3.3 Pharmacomechanical & Infusion Therapy
1.3.4 Venous Stenting
1.3.5 Vena Cava Filtration
1.3.6 Thermal Ablation
1.3.7 Non-thermal Closure
1.4 Market Segmentation by Clinical Indication
1.4.1 Global Venous Interventional Devices Market Size by Clinical Indication, 2021 vs 2025 vs 2032
1.4.2 Deep Vein Thrombosis
1.4.3 Chronic Venous Outflow Obstruction
1.4.4 VTE Risk Protection
1.4.5 Superficial Venous Insufficiency
1.4.6 Other
1.5 Market Segmentation by Application
1.5.1 Global Venous Interventional Devices Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Iliofemoral & Other Deep Veins
1.5.3 Inferior Vena Cava
1.5.4 Great & Small Saphenous Veins
1.5.5 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Global Venous Interventional Devices Revenue Estimates and Forecasts (2021-2032)
2.2 Global Venous Interventional Devices Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Venous Interventional Devices Sales Estimates and Forecasts (2021-2032)
2.4 Global Venous Interventional Devices Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)

3 Competitive Landscape
3.1 Global Venous Interventional Devices Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Venous Interventional Devices Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Venous Thrombectomy & CDT: Market Share by Key Manufacturers
3.5.2 Deep Venous Stenting: Market Share by Key Manufacturers
3.5.3 Vena Cava Filtration & Retrieval: Market Share by Key Manufacturers
3.5.4 Endovenous Ablation & Closure: Market Share by Key Manufacturers
3.5.5 Other: Market Share by Key Manufacturers
3.6 Global Venous Interventional Devices Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Product Segmentation
4.1 Global Venous Interventional Devices Sales Performance by Type
4.1.1 Global Venous Interventional Devices Sales Volume by Type (2021-2032)
4.1.2 Global Venous Interventional Devices Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Global Venous Interventional Devices Sales Performance by Treatment Mechanism
4.2.1 Global Venous Interventional Devices Sales Volume by Treatment Mechanism (2021-2032)
4.2.2 Global Venous Interventional Devices Revenue by Treatment Mechanism (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by Treatment Mechanism (2021-2032)
4.3 Global Venous Interventional Devices Sales Performance by Clinical Indication
4.3.1 Global Venous Interventional Devices Sales Volume by Clinical Indication (2021-2032)
4.3.2 Global Venous Interventional Devices Revenue by Clinical Indication (2021-2032)
4.3.3 Global Average Selling Price (ASP) Trends by Clinical Indication (2021-2032)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats

5 Downstream Applications and Customers
5.1 Global Venous Interventional Devices Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Venous Interventional Devices Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application

6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Venous Interventional Devices Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Venous Interventional Devices Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico

7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Venous Interventional Devices Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Venous Interventional Devices Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia

8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Venous Interventional Devices Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Venous Interventional Devices Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India

9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Venous Interventional Devices Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Venous Interventional Devices Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Venous Interventional Devices Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Venous Interventional Devices Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa

11 Corporate Profile
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Venous Interventional Devices Product Models, Descriptions and Specifications
11.1.4 Medtronic Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 Medtronic Venous Interventional Devices Sales by Product in 2025
11.1.6 Medtronic Venous Interventional Devices Sales by Application in 2025
11.1.7 Medtronic Venous Interventional Devices Sales by Geographic Area in 2025
11.1.8 Medtronic Venous Interventional Devices SWOT Analysis
11.1.9 Medtronic Recent Developments
11.2 BD
11.2.1 BD Corporation Information
11.2.2 BD Business Overview
11.2.3 BD Venous Interventional Devices Product Models, Descriptions and Specifications
11.2.4 BD Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 BD Venous Interventional Devices Sales by Product in 2025
11.2.6 BD Venous Interventional Devices Sales by Application in 2025
11.2.7 BD Venous Interventional Devices Sales by Geographic Area in 2025
11.2.8 BD Venous Interventional Devices SWOT Analysis
11.2.9 BD Recent Developments
11.3 Stryker
11.3.1 Stryker Corporation Information
11.3.2 Stryker Business Overview
11.3.3 Stryker Venous Interventional Devices Product Models, Descriptions and Specifications
11.3.4 Stryker Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 Stryker Venous Interventional Devices Sales by Product in 2025
11.3.6 Stryker Venous Interventional Devices Sales by Application in 2025
11.3.7 Stryker Venous Interventional Devices Sales by Geographic Area in 2025
11.3.8 Stryker Venous Interventional Devices SWOT Analysis
11.3.9 Stryker Recent Developments
11.4 Boston Scientific
11.4.1 Boston Scientific Corporation Information
11.4.2 Boston Scientific Business Overview
11.4.3 Boston Scientific Venous Interventional Devices Product Models, Descriptions and Specifications
11.4.4 Boston Scientific Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 Boston Scientific Venous Interventional Devices Sales by Product in 2025
11.4.6 Boston Scientific Venous Interventional Devices Sales by Application in 2025
11.4.7 Boston Scientific Venous Interventional Devices Sales by Geographic Area in 2025
11.4.8 Boston Scientific Venous Interventional Devices SWOT Analysis
11.4.9 Boston Scientific Recent Developments
11.5 Cook Medical
11.5.1 Cook Medical Corporation Information
11.5.2 Cook Medical Business Overview
11.5.3 Cook Medical Venous Interventional Devices Product Models, Descriptions and Specifications
11.5.4 Cook Medical Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Cook Medical Venous Interventional Devices Sales by Product in 2025
11.5.6 Cook Medical Venous Interventional Devices Sales by Application in 2025
11.5.7 Cook Medical Venous Interventional Devices Sales by Geographic Area in 2025
11.5.8 Cook Medical Venous Interventional Devices SWOT Analysis
11.5.9 Cook Medical Recent Developments
11.6 Penumbra
11.6.1 Penumbra Corporation Information
11.6.2 Penumbra Business Overview
11.6.3 Penumbra Venous Interventional Devices Product Models, Descriptions and Specifications
11.6.4 Penumbra Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 Penumbra Recent Developments
11.7 Merit Medical
11.7.1 Merit Medical Corporation Information
11.7.2 Merit Medical Business Overview
11.7.3 Merit Medical Venous Interventional Devices Product Models, Descriptions and Specifications
11.7.4 Merit Medical Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 Merit Medical Recent Developments
11.8 Abbott
11.8.1 Abbott Corporation Information
11.8.2 Abbott Business Overview
11.8.3 Abbott Venous Interventional Devices Product Models, Descriptions and Specifications
11.8.4 Abbott Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 Abbott Recent Developments
11.9 Argon Medical
11.9.1 Argon Medical Corporation Information
11.9.2 Argon Medical Business Overview
11.9.3 Argon Medical Venous Interventional Devices Product Models, Descriptions and Specifications
11.9.4 Argon Medical Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 Argon Medical Recent Developments
11.10 Philips
11.10.1 Philips Corporation Information
11.10.2 Philips Business Overview
11.10.3 Philips Venous Interventional Devices Product Models, Descriptions and Specifications
11.10.4 Philips Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 Philips Recent Developments
11.11 AngioDynamics
11.11.1 AngioDynamics Corporation Information
11.11.2 AngioDynamics Business Overview
11.11.3 AngioDynamics Venous Interventional Devices Product Models, Descriptions and Specifications
11.11.4 AngioDynamics Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 AngioDynamics Recent Developments
11.12 Cordis
11.12.1 Cordis Corporation Information
11.12.2 Cordis Business Overview
11.12.3 Cordis Venous Interventional Devices Product Models, Descriptions and Specifications
11.12.4 Cordis Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 Cordis Recent Developments
11.13 B. Braun
11.13.1 B. Braun Corporation Information
11.13.2 B. Braun Business Overview
11.13.3 B. Braun Venous Interventional Devices Product Models, Descriptions and Specifications
11.13.4 B. Braun Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 B. Braun Recent Developments
11.14 Bentley
11.14.1 Bentley Corporation Information
11.14.2 Bentley Business Overview
11.14.3 Bentley Venous Interventional Devices Product Models, Descriptions and Specifications
11.14.4 Bentley Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.14.5 Bentley Recent Developments
11.15 Optimed
11.15.1 Optimed Corporation Information
11.15.2 Optimed Business Overview
11.15.3 Optimed Venous Interventional Devices Product Models, Descriptions and Specifications
11.15.4 Optimed Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.15.5 Optimed Recent Developments
11.16 Biolitec
11.16.1 Biolitec Corporation Information
11.16.2 Biolitec Business Overview
11.16.3 Biolitec Venous Interventional Devices Product Models, Descriptions and Specifications
11.16.4 Biolitec Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.16.5 Biolitec Recent Developments
11.17 LSO Medical
11.17.1 LSO Medical Corporation Information
11.17.2 LSO Medical Business Overview
11.17.3 LSO Medical Venous Interventional Devices Product Models, Descriptions and Specifications
11.17.4 LSO Medical Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.17.5 LSO Medical Recent Developments
11.18 F Care Systems
11.18.1 F Care Systems Corporation Information
11.18.2 F Care Systems Business Overview
11.18.3 F Care Systems Venous Interventional Devices Product Models, Descriptions and Specifications
11.18.4 F Care Systems Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.18.5 F Care Systems Recent Developments
11.19 Balton
11.19.1 Balton Corporation Information
11.19.2 Balton Business Overview
11.19.3 Balton Venous Interventional Devices Product Models, Descriptions and Specifications
11.19.4 Balton Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.19.5 Balton Recent Developments
11.20 ALN
11.20.1 ALN Corporation Information
11.20.2 ALN Business Overview
11.20.3 ALN Venous Interventional Devices Product Models, Descriptions and Specifications
11.20.4 ALN Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.20.5 ALN Recent Developments
11.21 Acotec Scientific
11.21.1 Acotec Scientific Corporation Information
11.21.2 Acotec Scientific Business Overview
11.21.3 Acotec Scientific Venous Interventional Devices Product Models, Descriptions and Specifications
11.21.4 Acotec Scientific Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.21.5 Acotec Scientific Recent Developments
11.22 Zylox-Tonbridge
11.22.1 Zylox-Tonbridge Corporation Information
11.22.2 Zylox-Tonbridge Business Overview
11.22.3 Zylox-Tonbridge Venous Interventional Devices Product Models, Descriptions and Specifications
11.22.4 Zylox-Tonbridge Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.22.5 Zylox-Tonbridge Recent Developments
11.23 Endovastec
11.23.1 Endovastec Corporation Information
11.23.2 Endovastec Business Overview
11.23.3 Endovastec Venous Interventional Devices Product Models, Descriptions and Specifications
11.23.4 Endovastec Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.23.5 Endovastec Recent Developments
11.24 LifeTech Scientific
11.24.1 LifeTech Scientific Corporation Information
11.24.2 LifeTech Scientific Business Overview
11.24.3 LifeTech Scientific Venous Interventional Devices Product Models, Descriptions and Specifications
11.24.4 LifeTech Scientific Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.24.5 LifeTech Scientific Recent Developments
11.25 APT Medical
11.25.1 APT Medical Corporation Information
11.25.2 APT Medical Business Overview
11.25.3 APT Medical Venous Interventional Devices Product Models, Descriptions and Specifications
11.25.4 APT Medical Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.25.5 APT Medical Recent Developments
11.26 Shanghai EndoVas Medical Technologies
11.26.1 Shanghai EndoVas Medical Technologies Corporation Information
11.26.2 Shanghai EndoVas Medical Technologies Business Overview
11.26.3 Shanghai EndoVas Medical Technologies Venous Interventional Devices Product Models, Descriptions and Specifications
11.26.4 Shanghai EndoVas Medical Technologies Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.26.5 Shanghai EndoVas Medical Technologies Recent Developments
11.27 Mianyang Leader Electronics
11.27.1 Mianyang Leader Electronics Corporation Information
11.27.2 Mianyang Leader Electronics Business Overview
11.27.3 Mianyang Leader Electronics Venous Interventional Devices Product Models, Descriptions and Specifications
11.27.4 Mianyang Leader Electronics Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.27.5 Mianyang Leader Electronics Recent Developments
11.28 ECO Medical Technology
11.28.1 ECO Medical Technology Corporation Information
11.28.2 ECO Medical Technology Business Overview
11.28.3 ECO Medical Technology Venous Interventional Devices Product Models, Descriptions and Specifications
11.28.4 ECO Medical Technology Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.28.5 ECO Medical Technology Recent Developments
11.29 UNITAC
11.29.1 UNITAC Corporation Information
11.29.2 UNITAC Business Overview
11.29.3 UNITAC Venous Interventional Devices Product Models, Descriptions and Specifications
11.29.4 UNITAC Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.29.5 UNITAC Recent Developments
11.30 WONTECH
11.30.1 WONTECH Corporation Information
11.30.2 WONTECH Business Overview
11.30.3 WONTECH Venous Interventional Devices Product Models, Descriptions and Specifications
11.30.4 WONTECH Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.30.5 WONTECH Recent Developments
11.31 RF Medical
11.31.1 RF Medical Corporation Information
11.31.2 RF Medical Business Overview
11.31.3 RF Medical Venous Interventional Devices Product Models, Descriptions and Specifications
11.31.4 RF Medical Venous Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.31.5 RF Medical Recent Developments

12 Value Chain and Supply-Chain Analysis
12.1 Venous Interventional Devices Industry Chain
12.2 Venous Interventional Devices Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Venous Interventional Devices Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Venous Interventional Devices Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors

13 Venous Interventional Devices Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs

14 Key Findings in the Global Venous Interventional Devices Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Venous Interventional Devices Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Venous Interventional Devices Market Size Growth Rate by Treatment Mechanism, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Venous Interventional Devices Market Size Growth Rate by Clinical Indication, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Venous Interventional Devices Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Venous Interventional Devices Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Venous Interventional Devices Revenue by Region (US$ Million), 2021-2026
Table 7. Global Venous Interventional Devices Revenue by Region (US$ Million), 2027-2032
Table 8. Global Venous Interventional Devices Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Table 9. Global Venous Interventional Devices Sales by Region (K Units), 2021-2026
Table 10. Global Venous Interventional Devices Sales by Region (K Units), 2027-2032
Table 11. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 12. Global Venous Interventional Devices Sales by Manufacturers (K Units), 2021-2026
Table 13. Global Venous Interventional Devices Sales Share by Manufacturers (2021-2026)
Table 14. Global Venous Interventional Devices Revenue by Manufacturers (US$ Million), 2021-2026
Table 15. Global Venous Interventional Devices Revenue-Based Market Share by Manufacturers (2021-2026)
Table 16. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 17. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Venous Interventional Devices Revenue, 2025
Table 18. Global Venous Interventional Devices Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 19. Global Venous Interventional Devices Average Selling Price (ASP) by Manufacturers (US$/Unit), 2021-2026
Table 20. Key Manufacturers Venous Interventional Devices Manufacturing Base and Headquarters
Table 21. Global Venous Interventional Devices Market Concentration Ratio (CR5)
Table 22. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 23. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 24. Global Venous Interventional Devices Sales Volume by Type (K Units), 2021-2026
Table 25. Global Venous Interventional Devices Sales Volume by Type (K Units), 2027-2032
Table 26. Global Venous Interventional Devices Revenue by Type (US$ Million), 2021-2026
Table 27. Global Venous Interventional Devices Revenue by Type (US$ Million), 2027-2032
Table 28. Global Venous Interventional Devices Sales Volume by Treatment Mechanism (K Units), 2021-2026
Table 29. Global Venous Interventional Devices Sales Volume by Treatment Mechanism (K Units), 2027-2032
Table 30. Global Venous Interventional Devices Revenue by Treatment Mechanism (US$ Million), 2021-2026
Table 31. Global Venous Interventional Devices Revenue by Treatment Mechanism (US$ Million), 2027-2032
Table 32. Global Venous Interventional Devices Sales Volume by Clinical Indication (K Units), 2021-2026
Table 33. Global Venous Interventional Devices Sales Volume by Clinical Indication (K Units), 2027-2032
Table 34. Global Venous Interventional Devices Revenue by Clinical Indication (US$ Million), 2021-2026
Table 35. Global Venous Interventional Devices Revenue by Clinical Indication (US$ Million), 2027-2032
Table 36. Technical Specifications by Key Product Type
Table 37. Global Venous Interventional Devices Sales by Application (K Units), 2021-2026
Table 38. Global Venous Interventional Devices Sales by Application (K Units), 2027-2032
Table 39. Venous Interventional Devices High-Growth Sectors Demand CAGR (2026-2032)
Table 40. Global Venous Interventional Devices Revenue by Application (US$ Million), 2021-2026
Table 41. Global Venous Interventional Devices Revenue by Application (US$ Million), 2027-2032
Table 42. Top Customers by Region
Table 43. Top Customers by Application
Table 44. North America Venous Interventional Devices Growth Accelerators and Market Barriers
Table 45. North America Venous Interventional Devices Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 46. North America Venous Interventional Devices Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 47. Europe Venous Interventional Devices Growth Accelerators and Market Barriers
Table 48. Europe Venous Interventional Devices Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Europe Venous Interventional Devices Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 50. Asia-Pacific Venous Interventional Devices Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 51. Asia-Pacific Venous Interventional Devices Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 52. Asia-Pacific Venous Interventional Devices Growth Accelerators and Market Barriers
Table 53. Southeast Asia Venous Interventional Devices Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 54. Central and South America Venous Interventional Devices Investment Opportunities and Key Challenges
Table 55. Central and South America Venous Interventional Devices Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 56. Middle East and Africa Venous Interventional Devices Investment Opportunities and Key Challenges
Table 57. Middle East and Africa Venous Interventional Devices Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 58. Medtronic Corporation Information
Table 59. Medtronic Description and Major Businesses
Table 60. Medtronic Product Models, Descriptions and Specifications
Table 61. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 62. Medtronic Sales Value Proportion by Product in 2025
Table 63. Medtronic Sales Value Proportion by Application in 2025
Table 64. Medtronic Sales Value Proportion by Geographic Area in 2025
Table 65. Medtronic Venous Interventional Devices SWOT Analysis
Table 66. Medtronic Recent Developments
Table 67. BD Corporation Information
Table 68. BD Description and Major Businesses
Table 69. BD Product Models, Descriptions and Specifications
Table 70. BD Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 71. BD Sales Value Proportion by Product in 2025
Table 72. BD Sales Value Proportion by Application in 2025
Table 73. BD Sales Value Proportion by Geographic Area in 2025
Table 74. BD Venous Interventional Devices SWOT Analysis
Table 75. BD Recent Developments
Table 76. Stryker Corporation Information
Table 77. Stryker Description and Major Businesses
Table 78. Stryker Product Models, Descriptions and Specifications
Table 79. Stryker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Stryker Sales Value Proportion by Product in 2025
Table 81. Stryker Sales Value Proportion by Application in 2025
Table 82. Stryker Sales Value Proportion by Geographic Area in 2025
Table 83. Stryker Venous Interventional Devices SWOT Analysis
Table 84. Stryker Recent Developments
Table 85. Boston Scientific Corporation Information
Table 86. Boston Scientific Description and Major Businesses
Table 87. Boston Scientific Product Models, Descriptions and Specifications
Table 88. Boston Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Boston Scientific Sales Value Proportion by Product in 2025
Table 90. Boston Scientific Sales Value Proportion by Application in 2025
Table 91. Boston Scientific Sales Value Proportion by Geographic Area in 2025
Table 92. Boston Scientific Venous Interventional Devices SWOT Analysis
Table 93. Boston Scientific Recent Developments
Table 94. Cook Medical Corporation Information
Table 95. Cook Medical Description and Major Businesses
Table 96. Cook Medical Product Models, Descriptions and Specifications
Table 97. Cook Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Cook Medical Sales Value Proportion by Product in 2025
Table 99. Cook Medical Sales Value Proportion by Application in 2025
Table 100. Cook Medical Sales Value Proportion by Geographic Area in 2025
Table 101. Cook Medical Venous Interventional Devices SWOT Analysis
Table 102. Cook Medical Recent Developments
Table 103. Penumbra Corporation Information
Table 104. Penumbra Description and Major Businesses
Table 105. Penumbra Product Models, Descriptions and Specifications
Table 106. Penumbra Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Penumbra Recent Developments
Table 108. Merit Medical Corporation Information
Table 109. Merit Medical Description and Major Businesses
Table 110. Merit Medical Product Models, Descriptions and Specifications
Table 111. Merit Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Merit Medical Recent Developments
Table 113. Abbott Corporation Information
Table 114. Abbott Description and Major Businesses
Table 115. Abbott Product Models, Descriptions and Specifications
Table 116. Abbott Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Abbott Recent Developments
Table 118. Argon Medical Corporation Information
Table 119. Argon Medical Description and Major Businesses
Table 120. Argon Medical Product Models, Descriptions and Specifications
Table 121. Argon Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Argon Medical Recent Developments
Table 123. Philips Corporation Information
Table 124. Philips Description and Major Businesses
Table 125. Philips Product Models, Descriptions and Specifications
Table 126. Philips Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Philips Recent Developments
Table 128. AngioDynamics Corporation Information
Table 129. AngioDynamics Description and Major Businesses
Table 130. AngioDynamics Product Models, Descriptions and Specifications
Table 131. AngioDynamics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. AngioDynamics Recent Developments
Table 133. Cordis Corporation Information
Table 134. Cordis Description and Major Businesses
Table 135. Cordis Product Models, Descriptions and Specifications
Table 136. Cordis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Cordis Recent Developments
Table 138. B. Braun Corporation Information
Table 139. B. Braun Description and Major Businesses
Table 140. B. Braun Product Models, Descriptions and Specifications
Table 141. B. Braun Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. B. Braun Recent Developments
Table 143. Bentley Corporation Information
Table 144. Bentley Description and Major Businesses
Table 145. Bentley Product Models, Descriptions and Specifications
Table 146. Bentley Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Bentley Recent Developments
Table 148. Optimed Corporation Information
Table 149. Optimed Description and Major Businesses
Table 150. Optimed Product Models, Descriptions and Specifications
Table 151. Optimed Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Optimed Recent Developments
Table 153. Biolitec Corporation Information
Table 154. Biolitec Description and Major Businesses
Table 155. Biolitec Product Models, Descriptions and Specifications
Table 156. Biolitec Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. Biolitec Recent Developments
Table 158. LSO Medical Corporation Information
Table 159. LSO Medical Description and Major Businesses
Table 160. LSO Medical Product Models, Descriptions and Specifications
Table 161. LSO Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. LSO Medical Recent Developments
Table 163. F Care Systems Corporation Information
Table 164. F Care Systems Description and Major Businesses
Table 165. F Care Systems Product Models, Descriptions and Specifications
Table 166. F Care Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 167. F Care Systems Recent Developments
Table 168. Balton Corporation Information
Table 169. Balton Description and Major Businesses
Table 170. Balton Product Models, Descriptions and Specifications
Table 171. Balton Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 172. Balton Recent Developments
Table 173. ALN Corporation Information
Table 174. ALN Description and Major Businesses
Table 175. ALN Product Models, Descriptions and Specifications
Table 176. ALN Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 177. ALN Recent Developments
Table 178. Acotec Scientific Corporation Information
Table 179. Acotec Scientific Description and Major Businesses
Table 180. Acotec Scientific Product Models, Descriptions and Specifications
Table 181. Acotec Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 182. Acotec Scientific Recent Developments
Table 183. Zylox-Tonbridge Corporation Information
Table 184. Zylox-Tonbridge Description and Major Businesses
Table 185. Zylox-Tonbridge Product Models, Descriptions and Specifications
Table 186. Zylox-Tonbridge Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 187. Zylox-Tonbridge Recent Developments
Table 188. Endovastec Corporation Information
Table 189. Endovastec Description and Major Businesses
Table 190. Endovastec Product Models, Descriptions and Specifications
Table 191. Endovastec Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 192. Endovastec Recent Developments
Table 193. LifeTech Scientific Corporation Information
Table 194. LifeTech Scientific Description and Major Businesses
Table 195. LifeTech Scientific Product Models, Descriptions and Specifications
Table 196. LifeTech Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 197. LifeTech Scientific Recent Developments
Table 198. APT Medical Corporation Information
Table 199. APT Medical Description and Major Businesses
Table 200. APT Medical Product Models, Descriptions and Specifications
Table 201. APT Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 202. APT Medical Recent Developments
Table 203. Shanghai EndoVas Medical Technologies Corporation Information
Table 204. Shanghai EndoVas Medical Technologies Description and Major Businesses
Table 205. Shanghai EndoVas Medical Technologies Product Models, Descriptions and Specifications
Table 206. Shanghai EndoVas Medical Technologies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 207. Shanghai EndoVas Medical Technologies Recent Developments
Table 208. Mianyang Leader Electronics Corporation Information
Table 209. Mianyang Leader Electronics Description and Major Businesses
Table 210. Mianyang Leader Electronics Product Models, Descriptions and Specifications
Table 211. Mianyang Leader Electronics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 212. Mianyang Leader Electronics Recent Developments
Table 213. ECO Medical Technology Corporation Information
Table 214. ECO Medical Technology Description and Major Businesses
Table 215. ECO Medical Technology Product Models, Descriptions and Specifications
Table 216. ECO Medical Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 217. ECO Medical Technology Recent Developments
Table 218. UNITAC Corporation Information
Table 219. UNITAC Description and Major Businesses
Table 220. UNITAC Product Models, Descriptions and Specifications
Table 221. UNITAC Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 222. UNITAC Recent Developments
Table 223. WONTECH Corporation Information
Table 224. WONTECH Description and Major Businesses
Table 225. WONTECH Product Models, Descriptions and Specifications
Table 226. WONTECH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 227. WONTECH Recent Developments
Table 228. RF Medical Corporation Information
Table 229. RF Medical Description and Major Businesses
Table 230. RF Medical Product Models, Descriptions and Specifications
Table 231. RF Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 232. RF Medical Recent Developments
Table 233. Key Raw Materials Distribution
Table 234. Raw Materials Key Suppliers
Table 235. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 236. Milestones in Production Technology Evolution
Table 237. Distributors List
Table 238. Market Trends and Market Evolution
Table 239. Market Drivers and Opportunities
Table 240. Market Challenges, Risks, and Restraints
Table 241. Research Programs/Design for This Report
Table 242. Key Data Information from Secondary Sources
Table 243. Key Data Information from Primary Sources

List of Figures
Figure 1. Venous Interventional Devices Product Picture
Figure 2. Global Venous Interventional Devices Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Venous Thrombectomy & CDT Product Picture
Figure 4. Deep Venous Stenting Product Picture
Figure 5. Vena Cava Filtration & Retrieval Product Picture
Figure 6. Endovenous Ablation & Closure Product Picture
Figure 7. Other Product Picture
Figure 8. Global Venous Interventional Devices Market Size Growth Rate by Treatment Mechanism, 2021 vs 2025 vs 2032 (US$ Million)
Figure 9. Mechanical & Aspiration Thrombectomy Product Picture
Figure 10. Pharmacomechanical & Infusion Therapy Product Picture
Figure 11. Venous Stenting Product Picture
Figure 12. Vena Cava Filtration Product Picture
Figure 13. Thermal Ablation Product Picture
Figure 14. Non-thermal Closure Product Picture
Figure 15. Global Venous Interventional Devices Market Size Growth Rate by Clinical Indication, 2021 vs 2025 vs 2032 (US$ Million)
Figure 16. Deep Vein Thrombosis Product Picture
Figure 17. Chronic Venous Outflow Obstruction Product Picture
Figure 18. VTE Risk Protection Product Picture
Figure 19. Superficial Venous Insufficiency Product Picture
Figure 20. Other Product Picture
Figure 21. Global Venous Interventional Devices Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 22. Iliofemoral & Other Deep Veins
Figure 23. Inferior Vena Cava
Figure 24. Great & Small Saphenous Veins
Figure 25. Other
Figure 26. Venous Interventional Devices Report Years Considered
Figure 27. Global Venous Interventional Devices Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 28. Global Venous Interventional Devices Revenue (US$ Million), 2021-2032
Figure 29. Global Venous Interventional Devices Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 30. Global Venous Interventional Devices Revenue-Based Market Share by Region (2021-2032)
Figure 31. Global Venous Interventional Devices Sales (K Units), 2021-2032
Figure 32. Global Venous Interventional Devices Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 33. Global Venous Interventional Devices Sales Market Share by Region (2021-2032)
Figure 34. Top 5 and Top 10 Manufacturers Venous Interventional Devices Sales Volume Market Share in 2025
Figure 35. Global Venous Interventional Devices Revenue-Based Market Share Ranking (2025)
Figure 36. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 37. Venous Thrombectomy & CDT Revenue-Based Market Share by Manufacturer in 2025
Figure 38. Deep Venous Stenting Revenue-Based Market Share by Manufacturer in 2025
Figure 39. Vena Cava Filtration & Retrieval Revenue-Based Market Share by Manufacturer in 2025
Figure 40. Endovenous Ablation & Closure Revenue-Based Market Share by Manufacturer in 2025
Figure 41. Other Revenue-Based Market Share by Manufacturer in 2025
Figure 42. Global Venous Interventional Devices Sales Volume-Based Market Share by Type (2021-2032)
Figure 43. Global Venous Interventional Devices Revenue-Based Market Share by Type (2021-2032)
Figure 44. Global Venous Interventional Devices ASP by Type (US$/Unit), 2021-2032
Figure 45. Global Venous Interventional Devices Sales Volume-Based Market Share by Treatment Mechanism (2021-2032)
Figure 46. Global Venous Interventional Devices Revenue-Based Market Share by Treatment Mechanism (2021-2032)
Figure 47. Global Venous Interventional Devices ASP by Treatment Mechanism (US$/Unit), 2021-2032
Figure 48. Global Venous Interventional Devices Sales Volume-Based Market Share by Clinical Indication (2021-2032)
Figure 49. Global Venous Interventional Devices Revenue-Based Market Share by Clinical Indication (2021-2032)
Figure 50. Global Venous Interventional Devices ASP by Clinical Indication (US$/Unit), 2021-2032
Figure 51. Global Venous Interventional Devices Sales Market Share by Application (2021-2032)
Figure 52. Global Venous Interventional Devices Revenue-Based Market Share by Application (2021-2032)
Figure 53. Global Venous Interventional Devices ASP by Application (US$/Unit), 2021-2032
Figure 54. North America Venous Interventional Devices Sales YoY (K Units), 2021-2032
Figure 55. North America Venous Interventional Devices Revenue YoY (US$ Million), 2021-2032
Figure 56. North America Top 5 Manufacturers Venous Interventional Devices Sales Revenue (US$ Million) in 2025
Figure 57. North America Venous Interventional Devices Sales Volume (K Units) by Application (2021-2032)
Figure 58. North America Venous Interventional Devices Sales Revenue (US$ Million) by Application (2021-2032)
Figure 59. US Venous Interventional Devices Revenue (US$ Million), 2021-2032
Figure 60. Canada Venous Interventional Devices Revenue (US$ Million), 2021-2032
Figure 61. Mexico Venous Interventional Devices Revenue (US$ Million), 2021-2032
Figure 62. Europe Venous Interventional Devices Sales YoY (K Units), 2021-2032
Figure 63. Europe Venous Interventional Devices Revenue YoY (US$ Million), 2021-2032
Figure 64. Europe Top 5 Manufacturers Venous Interventional Devices Sales Revenue (US$ Million) in 2025
Figure 65. Europe Venous Interventional Devices Sales Volume (K Units) by Application (2021-2032)
Figure 66. Europe Venous Interventional Devices Sales Revenue (US$ Million) by Application (2021-2032)
Figure 67. Germany Venous Interventional Devices Revenue (US$ Million), 2021-2032
Figure 68. France Venous Interventional Devices Revenue (US$ Million), 2021-2032
Figure 69. U.K. Venous Interventional Devices Revenue (US$ Million), 2021-2032
Figure 70. Italy Venous Interventional Devices Revenue (US$ Million), 2021-2032
Figure 71. Russia Venous Interventional Devices Revenue (US$ Million), 2021-2032
Figure 72. Asia-Pacific Venous Interventional Devices Sales YoY (K Units), 2021-2032
Figure 73. Asia-Pacific Venous Interventional Devices Revenue YoY (US$ Million), 2021-2032
Figure 74. Asia-Pacific Top 8 Manufacturers Venous Interventional Devices Sales Revenue (US$ Million) in 2025
Figure 75. Asia-Pacific Venous Interventional Devices Sales Volume (K Units) by Application (2021-2032)
Figure 76. Asia-Pacific Venous Interventional Devices Sales Revenue (US$ Million) by Application (2021-2032)
Figure 77. Indonesia Venous Interventional Devices Revenue (US$ Million), 2021-2032
Figure 78. Japan Venous Interventional Devices Revenue (US$ Million), 2021-2032
Figure 79. South Korea Venous Interventional Devices Revenue (US$ Million), 2021-2032
Figure 80. China Taiwan Venous Interventional Devices Revenue (US$ Million), 2021-2032
Figure 81. India Venous Interventional Devices Revenue (US$ Million), 2021-2032
Figure 82. Central and South America Venous Interventional Devices Sales YoY (K Units), 2021-2032
Figure 83. Central and South America Venous Interventional Devices Revenue YoY (US$ Million), 2021-2032
Figure 84. Central and South America Top 5 Manufacturers Venous Interventional Devices Sales Revenue (US$ Million) in 2025
Figure 85. Central and South America Venous Interventional Devices Sales Volume (K Units) by Application (2021-2032)
Figure 86. Central and South America Venous Interventional Devices Sales Revenue (US$ Million) by Application (2021-2032)
Figure 87. Brazil Venous Interventional Devices Revenue (US$ Million), 2021-2032
Figure 88. Argentina Venous Interventional Devices Revenue (US$ Million), 2021-2032
Figure 89. Middle East, and Africa Venous Interventional Devices Sales YoY (K Units), 2021-2032
Figure 90. Middle East and Africa Venous Interventional Devices Revenue YoY (US$ Million), 2021-2032
Figure 91. Middle East and Africa Top 5 Manufacturers Venous Interventional Devices Sales Revenue (US$ Million) in 2025
Figure 92. Middle East and Africa Venous Interventional Devices Sales Volume (K Units) by Application (2021-2032)
Figure 93. Middle East and Africa Venous Interventional Devices Sales Revenue (US$ Million) by Application (2021-2032)
Figure 94. GCC Countries Venous Interventional Devices Revenue (US$ Million), 2021-2032
Figure 95. Turkey Venous Interventional Devices Revenue (US$ Million), 2021-2032
Figure 96. Egypt Venous Interventional Devices Revenue (US$ Million), 2021-2032
Figure 97. South Africa Venous Interventional Devices Revenue (US$ Million), 2021-2032
Figure 98. Venous Interventional Devices Industry Chain Mapping
Figure 99. Regional Venous Interventional Devices Manufacturing Base Distribution (%)
Figure 100. Global Venous Interventional Devices Production Market Share by Region (2021-2032)
Figure 101. Venous Interventional Devices Production Process
Figure 102. Regional Venous Interventional Devices Production Cost Structure
Figure 103. Channels of Distribution (Direct Vs Distribution)
Figure 104. Bottom-up and Top-down Approaches for This Report
Figure 105. Data Triangulation
Figure 106. Key Executives Interviewed